Trending...
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
- Daniel S. Romero, CFP® Earns Renowned Certification for Fiduciary Excellence
- California: Coho salmon are making a comeback in the Russian River for the first time in 30 years
MOUNTAIN VIEW, Calif. - Californer -- Adaptic Health, a leading provider of clinical development software, today announced the launch of its new platform designed to streamline the clinical trial design process. Clinical trials are essential for advancing medical research and bringing new treatments to patients, but they can be complex and time-consuming and the existing tools available for clinical study protocol development have not kept up with the increasing complexity. With the advent of new challenges such as remote approaches, genetic advancements, and diverse patient populations, the need for a more efficient and effective approach to trial design has become increasingly pressing.
Adaptic Health's platform provides biopharma companies with a digital infrastructure for clinical development, starting with trial design. The platform empowers Chief Medical Officers (CMOs) and clinical teams with collaboration tools, a dynamic literature review, and what-if analysis capabilities, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
"We are thrilled to bring this innovative solution to the market, especially in the wake of the COVID-19 pandemic, which has highlighted the need for accelerated trial design and execution across any disease area," said Luke Stewart and co-founder, CEO of Adaptic Health. "Our platform streamlines collaboration and enables users to learn from the past, explore different design tradeoffs, and accelerate protocol approval, all in one convenient and powerful platform."
More on The Californer
Adaptic Health's platform leverages previous experience to help CMOs and clinical teams improve the chances of success in their clinical trials. The platform consolidates historic FDA decisions and real-world data, providing a comprehensive resource for understanding the regulatory landscape and making informed decisions about trial design. Additionally, the platform's simulation tools allow users to explore different design tradeoffs and scenarios, such as the impact of different sample sizes or endpoint definitions, and see how they might affect the outcomes of the trial.
"The ability to simulate design tradeoffs is crucial for CMOs and other decision-makers who need to make informed choices about the direction and focus of their clinical trial development program," said Charles Barr, Chief Medical Officer and co-founder of Adaptic Health. "Our platform provides a powerful and convenient way to access and analyze data, making it easier for users to make informed decisions and optimize their trial design."
"Clinical trial design is a creative process. As such, inspiration is key. Adaptic Health brings the past into view so you can create the best future for your development program," said Stanley Lewis, CEO of A28 Therapeutics. "You also get faster stakeholder buy-in of your plan through the collaborative trial summary. By bringing this element into focus early, Adaptic accelerates the journey to clinical trial success."
More on The Californer
Visit us on our website at https://www.adaptichealth.io or email us at sales@adaptichealth.io to learn how you can get early access to the platform, now available in beta. The platform is expected to be generally available in 6 months.
About Adaptic Health
Adaptic Health offers a powerful software as a service (SaaS) platform that helps organizations accelerate clinical development from the earliest stage of design through biostatistical optimization. Our platform streamlines collaboration, enables dynamic literature review, and provides what-if analysis tools, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
Adaptic Health's platform provides biopharma companies with a digital infrastructure for clinical development, starting with trial design. The platform empowers Chief Medical Officers (CMOs) and clinical teams with collaboration tools, a dynamic literature review, and what-if analysis capabilities, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
"We are thrilled to bring this innovative solution to the market, especially in the wake of the COVID-19 pandemic, which has highlighted the need for accelerated trial design and execution across any disease area," said Luke Stewart and co-founder, CEO of Adaptic Health. "Our platform streamlines collaboration and enables users to learn from the past, explore different design tradeoffs, and accelerate protocol approval, all in one convenient and powerful platform."
More on The Californer
- 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
- The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
- TRIO Heating, Air & Plumbing Now Ranks #1 in San Jose
- Lights, camera, action! Governor Newsom announces 28 new films coming to California, set to boost local economies
Adaptic Health's platform leverages previous experience to help CMOs and clinical teams improve the chances of success in their clinical trials. The platform consolidates historic FDA decisions and real-world data, providing a comprehensive resource for understanding the regulatory landscape and making informed decisions about trial design. Additionally, the platform's simulation tools allow users to explore different design tradeoffs and scenarios, such as the impact of different sample sizes or endpoint definitions, and see how they might affect the outcomes of the trial.
"The ability to simulate design tradeoffs is crucial for CMOs and other decision-makers who need to make informed choices about the direction and focus of their clinical trial development program," said Charles Barr, Chief Medical Officer and co-founder of Adaptic Health. "Our platform provides a powerful and convenient way to access and analyze data, making it easier for users to make informed decisions and optimize their trial design."
"Clinical trial design is a creative process. As such, inspiration is key. Adaptic Health brings the past into view so you can create the best future for your development program," said Stanley Lewis, CEO of A28 Therapeutics. "You also get faster stakeholder buy-in of your plan through the collaborative trial summary. By bringing this element into focus early, Adaptic accelerates the journey to clinical trial success."
More on The Californer
- Milwaukee Job Corps Center Hosts Alumni Day, Calls Alumni to Action on Open Enrollment Campaign
- Connect Promotes Dr. Petra Stegmann as Head of Entrepreneurial Programs
- Xonicwave Expands Premier IT & Cybersecurity Services to San Diego Businesses
- Clean Comedy Kings Debuts At Black Oak Casino Saturday January 3rd
- Golden Paper Identifies Global Growth in Packaging Papers and Upgrades Its High-End Production Capacity
Visit us on our website at https://www.adaptichealth.io or email us at sales@adaptichealth.io to learn how you can get early access to the platform, now available in beta. The platform is expected to be generally available in 6 months.
About Adaptic Health
Adaptic Health offers a powerful software as a service (SaaS) platform that helps organizations accelerate clinical development from the earliest stage of design through biostatistical optimization. Our platform streamlines collaboration, enables dynamic literature review, and provides what-if analysis tools, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
Source: Adaptic Health
Filed Under: Health
0 Comments
Latest on The Californer
- Children Rising Appoints Marshelle A. Wilburn as New Executive Director
- Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
- Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles
- Bent Danholm Joins The American Dream TV as Central Florida Host
- Ship Overseas Inc Expands Heavy Equipment Shipping Operations into Africa
- The Nature of Miracles Celebrates 20th Anniversary Third Edition Published by DreamMakers Enterprises LLC
- Inboox.ai Launches Searchable Library of Real Marketing Emails Powered by AI Analysis
- Artificial Intelligence Leader Releases Children's Book on Veterans Day
- California continues to lead the nation in fusion energy, investing in technology of the future
- Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- IEI Introduces HTB-300-MTL-H: Ultra-Compact Medical AI Embedded System
- Mesa West Capital Funds $30 MM Loan for Acquisition of Industrial Asset in San Francisco Bay Area
- 40th Annual California Strawberry Festival Accepting Applications for Arts & Crafts Vendors
- Play with Purpose: Meemzy Magic Sensory Kits Support Child Development in a Fun Format
- California: Governor Newsom announces top former CDC officials to lead public health innovation, collaboration
- Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
- MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
- Celebrate Festively with Christmas Eyeglasses
- 'The Ambony' 2026 Media Kit Is Here